Implicity vs Triomics
Implicity answers to a device clinic and Triomics to a cancer program, so each has its own audience. Implicity's ILR ECG Analyzer reclassifies insertable cardiac monitor events. The vendor says it cuts false positives by 79% on Medtronic ILR recordings with 99% sensitivity. A Europace paper by Implicity authors covered 546 patients and 879 abnormal episodes and reported specificity of 76.0% and sensitivity of 98.6%. The homepage names no EHR, and the vendor says the platform can integrate with electronic health records.
Triomics adds pre-charting note drafts and registry abstraction to PRISM trial matching. The vendor says every registry field carries a citation, for NAACCR, SEER, COC and QOPI measures. Its homepage says four of ten top US cancer centers trust Triomics, and the vendor reports roughly 95% matching accuracy for PRISM from a 2024 npj Digital Medicine paper. Pricing runs through a demo request.
Decision support · Reviewed November 2, 2026
Implicity
by Implicity · founded 2016
Cloud platform for remote monitoring of pacemakers and ICDs, with AI alert filtering and heart failure risk scoring for device clinics.

Triomics
by triomics inc.
Oncology AI agents that match patients to clinical trials, prepare visits and curate cancer registries from notes, reports and faxes.
When to pick each one
Implicity
- AI reclassification of insertable monitor events
- ISO 13485 and ISO 27001 logos on its site
Triomics
- Registry curation for NAACCR, SEER, COC and QOPI
- Pre-charting note drafts for oncology visits
- Demo, 30-minute working session, synthetic-data sandbox
Score
Each row shows points earned of points available under the published rubric.
Implicity
36of 100
Triomics
12of 100
| Dimension | Implicity | Triomics | Difference |
|---|---|---|---|
| FDA clearance | 12 / 12 | 0 / 12 | +12 |
| HIPAA / SOC2 / BAA | 0 / 10 | 0 / 10 | 0 |
| EHR integrations (count) | 0 / 5.6 | 2.8 / 5.6 | -2.8 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 4.8 | 3.4 / 4.8 | -3.4 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 8.4 / 21 | 0 / 21 | +8.4 |
| RCT / meta-analysis / systematic review | 0 / 9 | 0 / 9 | 0 |
| Funding & adoption signal | 3 / 12 | 3 / 12 | 0 |
| Pricing transparency | 1.3 / 2.5 | 1.3 / 2.5 | 0 |
| Years in market | 6 / 6 | 0 / 6 | +6 |
Scroll horizontally to see every column.
Pricing
Implicity
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Triomics
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. Demo request and synthetic-data sandbox offered. |
Evidence
Implicity
FDA decisions
K253463 (opens in new tab)510(k)2026-07-02
ILR ECG Analyzer (IM007)
K230842 (opens in new tab)510(k)2023-10-25
SignalHF (IM008)
K210543 (opens in new tab)510(k)2021-11-03
IM007
Peer-reviewed
1 PubMed record names Implicity.
Triomics
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Implicity | Triomics |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Epic, OncoEMR, iKnowMed, Cerner |
| Founded | 2016 | n/a |
| HQ | FR | US |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.
